These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6732937)

  • 1. [Methodologic approach to individual evaluation of the pharmacodynamic effects of single doses of hydralazine, endralazine, prazosine and propranolol in hypertension patients].
    Izotov AI; Postol'nikov SF; Vygodin VA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):79-85. PubMed ID: 6732937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypotensive effect and tolerability of a short course of treatment with prazosin (pratsiol) and hydralazine (apressin) in a cooperative study of new drugs for the prevention of arterial hypertension].
    Kardiologiia; 1985 Jan; 25(1):23-8. PubMed ID: 3981857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hypertension with a combination of the adrenergic beta receptor blockader, obsidan, and the vasodilator, apressin].
    Erina EV; Ozokvo GI; Lediashova GA
    Ter Arkh; 1978; 50(11):112-7. PubMed ID: 725752
    [No Abstract]   [Full Text] [Related]  

  • 4. Using pharmacokinetics in drug therapy. V: Contributions to developing dosage regimens for antihypertensive drugs.
    Schumacher GE
    Am J Hosp Pharm; 1979 Sep; 36(9):1222-6. PubMed ID: 386789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of apressin and its combination with obzidan on central hemodynamic indices in the treatment of hypertension].
    Erina EV; Ozokvo GI
    Kardiologiia; 1978 Sep; 18(9):105-11. PubMed ID: 359890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of crystepin in combination with obsidan in patients with diabetes mellitus with arterial hypertension].
    Leviashvili BI
    Klin Med (Mosk); 1989 Mar; 67(3):34-7. PubMed ID: 2747151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and pharmacokinetic studies with the vasodilator endralazine.
    Elliott HL; Meredith PA; Reid JL
    J Hypertens Suppl; 1984 Dec; 2(3):S551-4. PubMed ID: 6599716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of studies on the clinical pharmacodynamics of cilazapril.
    Belz GG; Breithaupt K; Erb K
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S14-9. PubMed ID: 7898090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of hemodynamic findings from impedance cardiography in hypertensive stroke.
    Ramirez MF; Tibayan RT; Marinas CE; Yamamoto ME; Caguioa EV
    Am J Hypertens; 2005 Feb; 18(2 Pt 2):65S-72S. PubMed ID: 15752935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of long-term therapy with prazosin/propranolol on blood pressure and cardiopulmonary function in essential hypertension].
    Schaller K; Braun C; Krause E
    Z Gesamte Inn Med; 1990 Jun; 45(11):321-2. PubMed ID: 2118705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemodynamic effects of nisoldipine in young hypertensive patients.
    Zimlichman R; Zilberman D; Gold B
    Isr J Med Sci; 1995 May; 31(5):288-92. PubMed ID: 7759224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-finding study of the combination of pindolol, clopamide and endralazine in the treatment of moderate-to-severe hypertension.
    Seedat YK; Rawat R
    S Afr Med J; 1984 Nov; 66(18):682-4. PubMed ID: 6387966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regional and central hemodynamic changes during the treatment of hypertension with obsidan, apressin and their combination].
    Erina EV; Ozovko GI
    Kardiologiia; 1981 Mar; 21(3):14-9. PubMed ID: 7230593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
    Fea F; Salvioli G; Planca E; Pelliccioli I; Foti F; Colombo G
    Boll Soc Ital Cardiol; 1981; 26(12):2173-82. PubMed ID: 7185386
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacological studies with the vasodilator endralazine in normotensive subjects and essential hypertensives.
    Elliott HL; Meredith PA; Howden CW; Lawrie CB; Reid JL
    Int J Clin Pharmacol Res; 1984; 4(1):61-9. PubMed ID: 6469433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioimpedance cardiography measurements of cardiac output and other cardiovascular parameters.
    Albert NM
    Crit Care Nurs Clin North Am; 2006 Jun; 18(2):195-202, x. PubMed ID: 16728305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of nisoldipine in essential hypertension.
    Blau A; Herzog D; Herz I; Battler A; Schechter P; Eliahou HE
    Isr J Med Sci; 1994 Feb; 30(2):139-45. PubMed ID: 8150600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of once daily endralazine in hypertension.
    Wu R; Spence JD; Carruthers SG
    Eur J Clin Pharmacol; 1986; 30(5):553-7. PubMed ID: 3758143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.